ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.99
0.42%
US Tech 100
20,389.60
0.88%
S&P 500
6,032.38
0.56%
US Dollar vs CAD
1.40155
-0.01%
Bitcoin
96,523.35
-0.99%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Celularity Inc (CELU)

  7. Celularity Inc (CELU) News

CELU

Celularity (CELU)

Celularity Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CELU
DateTimeSourceHeadlineSymbolCompany
11/27/20244:00PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq NotificationNASDAQ:CELUCelularity Inc
11/20/20247:30AMGlobeNewswire Inc.Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia PacificNASDAQ:CELUCelularity Inc
11/18/20247:30AMGlobeNewswire Inc.Celularity Inc. Announces Resolution of Nasdaq Listing Compliance MatterNASDAQ:CELUCelularity Inc
11/07/20247:00AMGlobeNewswire Inc.Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 MillionNASDAQ:CELUCelularity Inc
10/23/20247:30AMGlobeNewswire Inc.Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings PanelNASDAQ:CELUCelularity Inc
10/22/20247:30AMGlobeNewswire Inc.Celularity Provides Corporate UpdateNASDAQ:CELUCelularity Inc
10/18/20245:00PMGlobeNewswire Inc.Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an AppealNASDAQ:CELUCelularity Inc
10/16/20244:15PMGlobeNewswire Inc.Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.NASDAQ:CELUCelularity Inc
09/05/20243:05PMGlobeNewswire Inc.Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment ConferenceNASDAQ:CELUCelularity Inc
08/28/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUCelularity Inc
08/28/20243:45PMGlobeNewswire Inc.Celularity Appoints Richard J. Berman to its Board of DirectorsNASDAQ:CELUCelularity Inc
08/23/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUCelularity Inc
08/23/20244:00PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUCelularity Inc
08/16/20243:45PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CELUCelularity Inc
08/05/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUCelularity Inc
07/31/20247:30AMGlobeNewswire Inc.Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023NASDAQ:CELUCelularity Inc
07/30/20243:26PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CELUCelularity Inc
06/03/20247:38AMGlobeNewswire Inc.Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CELUCelularity Inc
05/24/20244:15PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUCelularity Inc
05/14/20248:15AMGlobeNewswire Inc.Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T TherapyNASDAQ:CELUCelularity Inc
04/22/20247:00AMGlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research & Development DayNASDAQ:CELUCelularity Inc
04/19/20244:30PMGlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingNASDAQ:CELUCelularity Inc
04/18/20243:30PMGlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024NASDAQ:CELUCelularity Inc
04/15/20247:00AMGlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial ProductsNASDAQ:CELUCelularity Inc
04/08/20248:00AMGlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental CellsNASDAQ:CELUCelularity Inc
03/26/20248:00AMGlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3LNASDAQ:CELUCelularity Inc
03/20/20248:15AMGlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular DystrophyNASDAQ:CELUCelularity Inc
03/14/20248:15AMGlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE SummitNASDAQ:CELUCelularity Inc
03/12/20248:20AMGlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World CongressNASDAQ:CELUCelularity Inc
03/07/20248:35AMGlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental CellsNASDAQ:CELUCelularity Inc
 Showing the most relevant articles for your search:NASDAQ:CELU

Your Recent History

USOTC
WDLF
Decentral Life (PK)
AMEX
KULR
KULR Technology
NYSE
IONQ
IonQ
USOTC
RNVA
Rennova Health (CE)
USOTC
ERHE
ERHC Energy (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
QSEP
QS Energy (PK)
USOTC
IQST
iQSTEL (QX)
NASDAQ
SMCI
Super Micro Computer
USOTC
BIEL
Bioelectronics (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
COIN
XRPUSD
Ripple
USOTC
HMBL
HUMBL (PK)
USOTC
HIRU
Hiru (PK)
NASDAQ
ILLR
Triller
USOTC
ASII
Accredited Solutions (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49